<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s4 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 1; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 2; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt;counter-reset: d2 1; }
 #l4> li>*:first-child:before {counter-increment: d2; content: counter(d2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: d2 0;  }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 1; }
 #l5> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: f1 2; }
 #l6> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 li {display: block; }
 #l7 {padding-left: 0pt;counter-reset: g1 1; }
 #l7> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l8 {padding-left: 0pt;counter-reset: h1 2; }
 #l8> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 #l9 {padding-left: 0pt;counter-reset: h2 1; }
 #l9> li>*:first-child:before {counter-increment: h2; content: counter(h2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 li {display: block; }
 #l10 {padding-left: 0pt;counter-reset: i1 2; }
 #l10> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 #l11 {padding-left: 0pt;counter-reset: i2 1; }
 #l11> li>*:first-child:before {counter-increment: i2; content: counter(i2, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: i2 0;  }
 li {display: block; }
 #l12 {padding-left: 0pt;counter-reset: j1 1; }
 #l12> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: j1 0;  }
</style><!-- Basic Meta Tags -->
<meta charset="utf-8" />
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta name="viewport" content="width=device-width,initial-scale=1" />

<!-- Page Title and Description -->
<title>rgpv syllabus - rgpv timetable rgpv syllabus and rgpv timetable</title>
<meta name="description" content="Download and view the latest RGPV syllabus and timetable in PDF." />
<meta name="keywords" content="download, view, RGPV, syllabus, timetable, PDF" />

<!-- Robots Meta Tag -->
<meta name="robots" content="index, follow" />
<link rel="sitemap" href="/sitemap.xml" />

<!-- Twitter Meta Tags -->
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:title" content="RGPV Syllabus and Timetable" />
<meta name="twitter:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Open Graph Meta Tags -->
<meta property="og:locale" content="en_IN" />
<meta property="og:type" content="website" />
<meta property="og:site_name" content="RGPV Syllabus and Timetable" />
<meta property="og:title" content="RGPV Syllabus and Timetable" />
<meta property="og:description" content="Download and view the latest RGPV syllabus and timetable in PDF." />

<!-- Other Tags -->
<link rel="prefetch" />
<meta name="audience" content="all" />
<meta name="rating" content="general" />
<meta name="generator" content="site" />
<meta name="google" content="translate" />
<meta name="theme-color" content="#4DBA87" />
<meta name="geo.placename" content="India" />
<meta name="revisit-after" content="1 days" />
<meta property="fb:admins" content="100012765211323" />
<meta name="apple-mobile-web-app-capable" content="no" />

<!-- Apple Touch Icon -->
<meta name="apple-mobile-web-app-title" content="www.rgpv-syllabus-timetable.in" />
<meta name="apple-mobile-web-app-status-bar-style" content="default" />
<link rel="apple-touch-icon" href="/img/icons/apple-touch-icon-152x152.png" />

<!-- Favicon and Icons -->
<link rel="mask-icon" href="/img/icons/safari-pinned-tab.svg" color="#4DBA87" />
<link rel="icon" type="image/png" sizes="32x32" href="/img/icons/favicon-32x32.png" />
<link rel="icon" type="image/png" sizes="16x16" href="/img/icons/favicon-16x16.png" />
<meta name="msapplication-TileImage" content="/img/icons/msapplication-icon-144x144.png" />

<!-- Search Engine Tags -->
<meta name="search engines" content="Aeiwi, Alexa, AllTheWeb, AltaVista, AOL Netfind, Anzwers, Canada, DirectHit, EuroSeek, Excite, Overture, Go, Google, HotBot, InfoMak, Kanoodle, Lycos, MasterSite, National Directory, Northern Light, SearchIt, SimpleSearch, WebsMostLinked, WebTop, What-U-Seek, AOL, Yahoo, WebCrawler, Infoseek, Excite, Magellan, LookSmart, CNET, Googlebot" />

<!-- Pingback and OpenID -->
<link rel="pingback" href="https://www.rgpv-syllabus-timetable.in/" />
<link rel="openid.delegate" href="https://www.rgpv-syllabus-timetable.in/" />

<!-- Content Type -->
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download PDF</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 12pt;text-indent: 0pt;text-align: center;">PHARMACEUTICAL QUALITY ASSURANCE (MQA)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 137pt;text-indent: -110pt;line-height: 114%;text-align: left;">MODERN PHARMACEUTICAL ANALYTICAL TECHNIQUES (MQA 101T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This subject deals with various advanced analytical instrumental techniques for identification, characterization and quantification of drugs. Instruments dealt are NMR, Mass spectrometer, IR, HPLC, GC etc.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">After completion of course student is able to know about chemicals and excipients</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The analysis of various drugs in single and combination dosage forms</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Theoretical and practical skills of the instruments</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><ol id="l1"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">a. <span class="s3">UV-Visible spectroscopy</span>: Introduction, Theory, Laws, Instrumentation associated with UV-Visible spectroscopy, Choice of solvents and solvent effect and Applications of UV-Visible spectroscopy, Difference/ Derivative spectroscopy.</p><ol id="l2"><li data-list-text="b."><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">IR spectroscopy<span class="p">: Theory, Modes of Molecular vibrations, Sample handling, Instrumentation of Dispersive and Fourier - Transform IR Spectrometer, Factors affecting vibrational frequencies and Applications of IR spectroscopy, Data Interpretation.</span></p></li><li data-list-text="c."><p class="s3" style="padding-left: 41pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Spectroflourimetry: <span class="p">Theory  of  Fluorescence,  Factors</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">affecting fluorescence (Characterestics of drugs that can be analysed by flourimetry), Quenchers, Instrumentation and Applications of fluorescence spectrophotometer.</p></li><li data-list-text="d."><p class="s3" style="padding-left: 41pt;text-indent: -14pt;line-height: 10pt;text-align: justify;">Flame  emission  spectroscopy  and  Atomic  absorption</p></li></ol></li></ol><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 88%;text-align: justify;">spectroscopy<span class="p">: Principle, Instrumentation, Interferences and Applications.</span></p><ol id="l3"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">NMR spectroscopy<span class="p">: Quantum numbers and their role in NMR, Principle, Instrumentation, Solvent requirement in NMR, Relaxation process, NMR signals in various compounds, Chemical shift, Factors influencing chemical shift, Spin-Spin coupling, Coupling constant, Nuclear magnetic double resonance, Brief outline of principles of FT-NMR and 13C NMR. Applications of NMR spectroscopy.</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="3"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Mass Spectroscopy<span class="p">: Principle, Theory, Instrumentation of Mass Spectroscopy, Different types of ionization like electron impact, chemical, field, FAB and MALDI, APCI, ESI, APPI Analyzers of Quadrupole and Time of Flight, Mass fragmentation and its rules, Meta stable ions, Isotopic peaks and Applications of Mass spectroscopy.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Chromatography<span class="p">:  Principle,  apparatus,  instrumentation, chromatographic parameters, factors affecting resolution, isolation of drug from excipients, data interpretation and applications of the following:</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Thin Layer chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">High Performance Thin Layer Chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Ion exchange chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Column chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Gas chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">High Performance Liquid chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Ultra High Performance Liquid chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Affinity chromatography</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Gel Chromatography</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">a.  <span class="s3">Electrophoresis</span>:  Principle,  Instrumentation,  Working conditions, factors affecting separation and applications of the following:</p><ol id="l4"><li data-list-text="a)"><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Paper electrophoresis b) Gel electrophoresis c) Capillary electrophoresis d) Zone electrophoresis e) Moving boundary electrophoresis f) Iso electric focusing</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">b. <span class="s3">X ray Crystallography</span>: Production of X rays, Different X ray</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">methods, Bragg‘s law, Rotating crystal technique, X ray powder technique, Types of crystals and applications of X-ray diffraction.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="6"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 87%;text-align: justify;">a. <span class="s3">Potentiometry: </span>Principle, working, Ion selective Electrodes and Application of potentiometry.</p></li></ol><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">b. Thermal Techniques<span class="p">: Principle, thermal transitions and Instrumentation (Heat flux and power-compensation and designs), Modulated DSC, Hyper DSC, experimental parameters (sample preparation, experimental conditions, calibration, heating and cooling rates, resolution, source of errors) and their influence, advantage and disadvantages, pharmaceutical applications. Differential Thermal Analysis (DTA): Principle, instrumentation</span></p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">and advantage and disadvantages, pharmaceutical applications, derivative differential thermal analysis (DDTA). TGA: Principle, instrumentation, factors affecting results, advantage and disadvantages, pharmaceutical applications.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l5"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Spectrometric Identification of Organic compounds - Robert M Silverstein, Sixth edition, John Wiley &amp; Sons, 2004.</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5<span class="s4">th </span>edition, Eastern press, Bangalore, 1998.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Instrumental methods of analysis – Willards, 7th edition, CBS publishers.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Practical Pharmaceutical Chemistry – Beckett and Stenlake, Vol II, 4th edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Organic Spectroscopy - William Kemp, 3rd edition, ELBS, 1991.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical formulation - P D Sethi, 3rd Edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Pharmaceutical Analysis - Modern Methods – Part B - J W Munson, Vol 11, Marcel. Dekker Series</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Spectroscopy of Organic Compounds, 2<span class="s4">nd </span>edn., P.S/Kalsi, Wiley estern Ltd., Delhi.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 88%;text-align: left;">Textbook of Pharmaceutical Analysis, KA.Connors, 3<span class="s4">rd </span>Edition, John Wiley &amp; Sons, 1982.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Textbook of Pharmaceutical Analysis, KA.Connors, 3<span class="s4">rd </span>Edition, John Wiley &amp; Sons, 1982.</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 137pt;text-indent: -57pt;line-height: 113%;text-align: left;">QUALITY MANAGEMENT SYSTEMS (MQA 102T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This course is designed to impart fundamental knowledge and concepts about various quality management principles and systems utilized in the manufacturing industry. It also aids in understanding the quality evaluation in the pharmaceutical industries.</p><p class="s3" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 88%;text-align: left;">At completion of this course it is expected that students will be able to understand-</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The importance of quality</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">ISO management systems</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Tools for quality improvement</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Analysis of issues in quality</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Quality evaluation of pharmaceuticals</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Stability testing of drug and drug substances</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Statistical approaches for quality</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                               60 Hrs</p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: -22pt;line-height: 75%;text-align: justify;">1. <span class="s3">Introduction to Quality: </span>Evolution of Quality, Definition of Quality, Dimensions of Quality</p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 87%;text-align: justify;">Quality as a Strategic Decision: <span class="p">Meaning of strategy and strategic quality management, mission and vision statements, quality policy, Quality objectives, strategic planning and implementation, McKinsey 7s model, Competitive analysis, Management commitment to quality</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">Customer Focus: <span class="p">Meaning of customer and customer focus, Classification of customers, Customer focus, Customer perception of quality, Factors affecting customer perception, Customer requirements, Meeting customer needs and expectations, Customer satisfaction and Customer delight, Handling customer complaints, Understanding customer behavior, concept of internal and external customers. Case studies.</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Cost of Quality: <span class="p">Cost of quality, Categories of cost of Quality, Models of cost of quality, Optimising costs, Preventing cost of quality.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><ol id="l6"><li data-list-text="2"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Pharmaceutical  quality  Management:  <span class="p">Basics  of  Quality Management, Total Quality Management (TQM), Principles of Six sigma, ISO 9001:2008, 9001:2015, ISO 14001:2004,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Pharmaceutical Quality Management – ICH Q10, Knowledge management, Quality Metrics, Operational Excellence and Quality Management Review. OSHAS guidelines, NABL certification and accreditation, CFR-21 part 11, WHO-GMP requirements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Six System Inspection model: <span class="p">Quality Management system, Production system, Facility and Equipment system, Laboratory control system, Materials system, Packaging and labeling system. Concept of self inspection.</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Quality systems: <span class="p">Change Management/ Change control.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Deviations, Out of Specifications (OOS), Out of Trend (OOT), Complaints - evaluation and handling, Investigation and determination of root cause, Corrective &amp; Preventive Actions (CAPA), Returns and Recalls, Vendor Qualification, Annual Product Reviews, Batch Review and Batch Release. Concept of IPQC, area clearance/ Line clearance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Drug Stability: <span class="p">ICH guidelines for stability testing of drug substances and drug products.</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Study of  ICH  Q8,  Quality  by  Design  and  Process</p><p class="s3" style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;text-align: justify;">development report</p><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Quality risk management: <span class="p">Introduction, risk assessment, risk control, risk review, risk management tools, HACCP, risk ranking and filtering according to ICH Q9 guidelines</span>.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Statistical Process control (SPC): <span class="p">Definition and Importance of SPC, Quality measurement in manufacturing, Statistical control charts - concepts and general aspects, Advantages of statistical control, Process capability, Estimating Inherent or potential capability from a control chart analysis, Measuring process control and quality improvement, Pursuit of decreased process variability.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="6"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Regulatory Compliance through Quality Management and development of Quality Culture</p></li></ol><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Benchmarking: Definition of benchmarking, Reasons for benchmarking, Types of Benchmarking, Benchmarking process, Advantages of benchmarking, Limitations of benchmarking.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">8 Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">4 Hrs</p><p class="s3" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l7"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 26pt;text-indent: -14pt;line-height: 74%;text-align: justify;">Implementing Juran&#39;s Road Map for Quality Leadership: Benchmarks and Results, By Al Endres, Wiley, 2000</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Understanding, Managing and Implementing Quality: Frameworks, Techniques and Cases, By Jiju Antony; David Preece, Routledge, 2002</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Organizing for High Performance: Employee Involvement, TQM, Reengineering, and Knowledge Management in the Fortune 1000: The CEO Report By Edward E. Lawler; Susan Albers Mohrman; George Benson, Jossey-Bass, 2001</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Corporate Culture and the Quality Organization By James W. Fairfield- Sonn, Quorum Books, 2001</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">The Quality Management Sourcebook: An International Guide to Materials and Resources By Christine Avery; Diane Zabel, Routledge, 1997</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: justify;">The Quality Toolbox, Second Edition, Nancy R. Tague, ASQ Publications</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Juran&#39;s Quality Handbook, Sixth Edition, Joseph M. Juran and Joseph A. De Feo, ASQ Publications</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: justify;">Root Cause Analysis, The Core of Problem Solving and Corrective Action, Duke Okes, 2009, ASQ Publications.</p></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 50pt;text-indent: 0pt;line-height: 113%;text-align: center;">QUALITY CONTROL AND QUALITY ASSURANCE (MQA 103T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: justify;">This course deals with the various aspects of quality control and quality assurance aspects of pharmaceutical industries. It covers the important aspects like cGMP, QC tests, documentation, quality certifications, GLP and regulatory affairs<span class="s3">.</span></p><p class="s3" style="padding-top: 8pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Upon completion of this course the student should be able to</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Understand the cGMP aspects in a pharmaceutical industry</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">To appreciate the importance of documentation</span></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: left;">  <span class="p">To understand the scope of quality certifications applicable to Pharmaceutical industries</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">To understand the responsibilities of QA &amp; QC departments.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 12pt;text-indent: 0pt;text-align: center;">THEORY                                 60 Hrs</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1.  <span class="s3">Introduction:  </span>Concept and evolution and scopes of Quality Control and Quality Assurance, Good Laboratory Practice, GMP, Overview of ICH Guidelines - QSEM, with special emphasis on Q- series guidelines.</p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Good Laboratory Practices: <span class="p">Scope of GLP, Definitions, Quality</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">assurance unit, protocol for conduct of non clinical testing, control on animal house, report preparation and documentation. CPCSEA guidelines.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l8"><li data-list-text="2"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">cGMP guidelines according to schedule M, USFDA (inclusive of CDER and CBER) Pharmaceutical Inspection Convention(PIC), WHO and EMEA covering: Organization and personnel responsibilities, training, hygiene and personal records, drug industry location, design, construction and plant lay out, maintenance, sanitation, environmental control, utilities and maintenance of sterile areas, control of contamination and Good Warehousing Practice.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Analysis of raw materials, finished products, packaging materials, in process quality control (IPQC), Developing specification (ICH Q6 and Q3), purchase specifications and maintenance of stores for raw materials.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">In process quality control and finished products quality control for following dosage forms in Pharma industry according to Indian, US and British pharmacopoeias: tablets, capsules, ointments, suppositories, creams, parenterals, ophthalmic and surgical products (How to refer pharmacopoeias).</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s3" style="padding-top: 4pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Documentation  in  pharmaceutical  industry:  <span class="p">Three  tier documentation, Policy, Procedures and Work instructions, and records (Formats), Basic principles- How to maintain, retention and retrieval etc. Standard operating procedures (How to write), Master Batch Record, Batch Manufacturing Record, Quality audit plan and reports. Specification and test procedures, Protocols and reports. Distribution records. Electronic data handling. Concepts of controlled and uncontrolled documents.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 83%;text-align: justify;">Submission documents for regulators DMFs, as Common Technical Document and Electronic Common Technical Documentation (CTD, eCTD). Concept of regulated and non regulated markets.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Manufacturing  operations  and  controls:  <span class="p">Sanitation  of manufacturing premises, mix-ups and cross contamination, processing of intermediates and bulk products, packaging operations, IPQC, release of finished product, process deviations, charge-in of components, time limitations on production, drug product inspection, expiry date calculation, calculation of yields, production record review, change control, sterile products, aseptic process control, packaging, reprocessing, salvaging, handling of waste and scrap disposal.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Introduction, scope and importance of intellectual property rights. Concept of trade mark, copyright and patents.</p><p class="s3" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><ol id="l9"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quality Assurance Guide by organization of Pharmaceutical Procedures of India, 3<span class="s4">rd </span>revised edition, Volume I &amp; II, Mumbai, 1996.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 88%;text-align: left;">Good Laboratory Practice Regulations, 2<span class="s4">nd </span>Edition, Sandy Weinberg Vol. 69, Marcel Dekker Series, 1995.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quality Assurance of Pharmaceuticals- A compedium of Guide lines and Related materials Vol I &amp; II, 2<span class="s4">nd </span>edition, WHO Publications, 1999.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">How to Practice GMP’s – P P Sharma, Vandana Publications, Agra, 1991.</p></li><li data-list-text="5."><p style="padding-top: 2pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">The International Pharmacopoeia – vol I, II, III, IV &amp; V - General Methods of Analysis and Quality specification for Pharmaceutical Substances, Excepients and Dosage forms, 3<span class="s4">rd </span>edition, WHO, Geneva, 2005.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Good laboratory Practice Regulations – Allen F. Hirsch, Volume 38, Marcel</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Dekker Series, 1989.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: justify;">ICH guidelines</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: justify;">ISO 9000 and total quality management</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">The drugs and cosmetics act 1940 – Deshpande, Nilesh Gandhi, 4<span class="s4">th </span>edition, Susmit Publishers, 2006.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: justify;">QA Manual – D.H. Shah, 1<span class="s4">st </span>edition, Business Horizons, 2000.</p></li><li data-list-text="11."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Good Manufacturing Practices for Pharmaceuticals a plan for total quality control – Sidney H. Willig, Vol. 52, 3<span class="s4">rd </span>edition, Marcel Dekker Series.</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Steinborn L. GMP/ISO Quality Audit Manual for Healthcare Manufacturers and Their Suppliers, Sixth Edition, (Volume 1 - With Checklists and Software Package). Taylor &amp; Francis; 2003.</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Sarker DK. Quality Systems and Controls for Pharmaceuticals. John Wiley</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">&amp; Sons; 2008.</p></li><li data-list-text="14."><p style="padding-left: 12pt;text-indent: 0pt;line-height: 91%;text-align: justify;">Packaging of Pharmaceuticals. 15.Schedule M and Schedule N.</p></li></ol></li></ol><p class="s2" style="padding-top: 3pt;padding-left: 137pt;text-indent: -113pt;line-height: 114%;text-align: left;">PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER (MQA 104T)</p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This deal with technology transfer covers the activities associated with Drug Substance, Drug Product and analytical tests and methods, required following candidate drug selection to completion of technology transfer from R&amp;D to the first receiving site and technology transfer related to post-marketing changes in manufacturing places.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Upon completion of this course the student should be able to</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">  <span class="p">To understand the new product development process</span></p><p class="s3" style="padding-top: 1pt;padding-left: 41pt;text-indent: -18pt;line-height: 87%;text-align: justify;"> <span class="p">To understand the necessary information to transfer technology from R&amp;D to actual manufacturing by sorting out various information obtained during R&amp;D</span></p><p class="s3" style="padding-left: 41pt;text-indent: -18pt;line-height: 88%;text-align: justify;"> <span class="p">To elucidate necessary information to transfer technology of existing products between various manufacturing places</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 5pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">1. <span class="s3">Principles of  Drug  discovery and development: </span>Introduction, Clinical research process. Development and informational content for Investigational New Drugs Application (IND), New Drug Application (NDA), Abbreviated New Drug Application (ANDA), Supplemental New Drug Application (SNDA), Scale Up Post Approval Changes (SUPAC) and Bulk active chemical Post approval changes (BACPAC), Post marketing surveillance, Product registration guidelines – CDSCO, USFDA.</p><ol id="l10"><li data-list-text="2"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Pre-formulation  studies:  <span class="p">Introduction/concept, organoleptic properties, purity, impurity profiles, particle size, shape and surface area. Solubility, Methods to improve solubility of Drugs: Surfactants &amp; its importance, co-solvency. Techniques for the study of Crystal properties and polymorphism. Pre-formulation protocol, Stability testing during product development.</span></p></li><li data-list-text="3"><p class="s3" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Pilot plant scale up: <span class="p">Concept, Significance, design, layout of pilot plant scale up study, operations, large scale manufacturing techniques (formula, equipment, process, stability and quality control) of solids, liquids, semisolid and parenteral dosage forms. New era of drug products: opportunities and challenges.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="4"><p class="s3" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: justify;">Pharmaceutical packaging: <span class="p">Pharmaceutical dosage form and their packaging requirments, Pharmaceutical packaging materials, Medical device packaging, Enteral Packaging, Aseptic packaging systems, Container closure systems, Issues facing modern drug packaging, Selection and evaluation of Pharmaceutical packaging materials.</span></p><p class="s3" style="padding-left: 27pt;text-indent: 0pt;line-height: 90%;text-align: justify;">Quality control test<span class="p">: Containers, closures and secondary packing materials.</span></p></li><li data-list-text="5"><p class="s3" style="padding-left: 28pt;text-indent: -22pt;line-height: 9pt;text-align: justify;">Technology transfer: <span class="p">Development of technology by R &amp; D,</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Technology transfer from R &amp; D to production, Optimization and Production, Qualitative and quantitative technology models.</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 83%;text-align: justify;">Documentation in technology transfer: Development report, technology transfer plan and Exhibit.</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l11"><li data-list-text="1."><p style="padding-top: 5pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">The process of new drug discovery and development. I and II Edition (2006) by Charles G. Smith, James T and O. Donnell. CRC Press, Group of Taylor and Francis.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: justify;">Leon Lac Lachman, Herbert A. Liberman, Theory and Practice of Industrial</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Pharmacy. Marcel Dekker Inc. New York.</p></li><li data-list-text="3."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Sidney H Willing, Murray M, Tuckerman. Williams Hitchings IV, Good manufacturing of pharmaceuticals (A Plan for total quality control) 3rd Edition. Bhalani publishing house Mumbai.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">Tablets Vol. I, II, III by Leon Lachman, Herbert A. Liberman, Joseph B. Schwartz, 2nd Edn. (1989) Marcel Dekker Inc. New York.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: justify;">Text book of Bio- Pharmaceutics and clinical Pharmacokinetics by Milo Gibaldi, 3<span class="s4">rd </span>Edn, Lea &amp; Febriger, Philadelphia.</p></li><li data-list-text="6."><p style="padding-left: 28pt;text-indent: -15pt;line-height: 86%;text-align: justify;">Pharmaceutical product development. Vandana V. Patrevale. John I. Disouza. Maharukh T.Rustomji. CRC Press, Group of Taylor and Francis.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Dissolution, Bioavailability and Bio-Equivalence by Abdou H.M, Mack Publishing company, Eastern Pennsylvania.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Remingtons Pharmaceutical Sciences, by Alfonso &amp; Gennaro, 19th Edn.(1995)OO2C Lippincott; Williams and Wilkins A Wolters Kluwer Company, Philadelphia.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: justify;">The Pharmaceutical Sciences; the Pharma Path way ‘Pure and applied Pharmacy’ by D. A Sawant, Pragathi Books Pvt. Ltd.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: justify;">Pharmaceutical Packaging technology by D.A. Dean. E.R. Evans, I.H. Hall.</p></li></ol></li></ol><p style="padding-left: 26pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">1<span class="s4">st </span>Edition(Reprint 2006). Taylor and Francis. London and New York.</p><p class="s2" style="padding-top: 3pt;padding-left: 137pt;text-indent: -61pt;line-height: 113%;text-align: left;">QUALITY ASSURANCE PRACTICAL - I (MQA 105P)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">PRACTICALS</p><ol id="l12"><li data-list-text="1."><p style="padding-top: 6pt;padding-left: 23pt;text-indent: -18pt;line-height: 74%;text-align: left;">Analysis of Pharmacopoeial compounds in bulk and in their formulations (tablet/ capsules/ semisolids) by UV Vis spectrophotometer</p></li><li data-list-text="2."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 86%;text-align: left;">Simultaneous estimation of multi-drug component containing formulations by UV spectrophotometry</p></li><li data-list-text="3."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 10pt;text-align: left;">Experiments based on HPLC</p></li><li data-list-text="4."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Experiments based on Gas Chromatography</p></li><li data-list-text="5."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Estimation of riboflavin/quinine sulphate by fluorimetry</p></li><li data-list-text="6."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Estimation of sodium/potassium by flame photometry or AAS</p></li><li data-list-text="7."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Case studies on</p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;"> <span class="p">Total Quality Management</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;"> <span class="p">Six Sigma</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;"> <span class="p">Change Management/ Change control. Deviations,</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;"> <span class="p">Out of Specifications (OOS)</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Out of Trend (OOT)</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Corrective &amp; Preventive Actions (CAPA)</span></p><p class="s3" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;"> <span class="p">Deviations</span></p></li><li data-list-text="8."><p style="padding-left: 23pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Development of Stability study protocol</p></li><li data-list-text="9."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Estimation of process capability</p></li><li data-list-text="10."><p style="padding-top: 1pt;padding-left: 23pt;text-indent: -18pt;line-height: 85%;text-align: left;">In process and finished product quality control tests for tablets, capsules, parenterals and semisolid dosage forms.</p></li><li data-list-text="11."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Assay of raw materials as per official monographs</p></li><li data-list-text="12."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Testing of related and foreign substances in drugs and raw materials</p></li><li data-list-text="13."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">To carry out pre formulation study for tablets, parenterals (2 experiment).</p></li><li data-list-text="14."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">To study the effect of pH on the solubility of drugs, (1 experiment)</p></li><li data-list-text="15."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Quality control tests for Primary and secondary packaging materials</p></li><li data-list-text="16."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Accelerated stability studies (1 experiment)</p></li><li data-list-text="17."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Improved solubility of drugs using surfactant systems (1 experiment)</p></li><li data-list-text="18."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Improved solubility of drugs using co-solvency method (1 experiment)</p></li><li data-list-text="19."><p style="padding-left: 23pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Determination of Pka and Log p of drugs.</p></li></ol></body></html>
